Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins.
about
Five things every community pharmacist should know when dispensing for 4-legged patientsISFM consensus guidelines on the practical management of diabetes mellitus in cats.Glycemic status and predictors of relapse for diabetic cats in remission.An individual approach to feline diabetes care: a case report and literature reviewMonitoring methods for dogs and cats with diabetes mellitus.Feline diabetes mellitus: clinical use of long-acting glargine and detemir.Hypoglycemic episodes in cats with diabetes mellitus: 30 cases (2013-2015).The use of oral recombinant feline interferon omega in two cats with type II diabetes mellitus and concurrent feline chronic gingivostomatitis syndrome.Intramuscular glargine with or without concurrent subcutaneous administration for treatment of feline diabetic ketoacidosis.A survey of Southeastern United States veterinarians' preferences for managing cats with diabetes mellitus.Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control.Effect of dietary carbohydrate, fat, and protein on postprandial glycemia and energy intake in cats.Prospective evaluation of a protocol for transitioning porcine lente insulin-treated diabetic cats to human recombinant protamine zinc insulin.Acceptance of home blood glucose monitoring by owners of recently diagnosed diabetic cats and impact on quality of life changes in cat and owner.Insulin detemir treatment in diabetic cats in a practice setting.Diabetes mellitus remission in a cat with pituitary-dependent hyperadrenocorticism after trilostane treatment.
P2860
Q26748584-8C0BD205-ABF0-485D-BE29-600AF74FC8A8Q34463927-2BFE3CD3-CFBF-4C4A-8322-EFBC0E05C20BQ36873641-C44C66A5-951B-491C-BF6C-87166D24F124Q37356560-771B8931-3BA7-4FF6-BD7E-E3BAA606F468Q38024381-1A459729-5469-4977-B708-533EC5EC3564Q38190526-73D0D891-67AD-4143-BD69-1722F5E30323Q38620733-96217B8B-13FF-4CB1-86D5-30B556158FB4Q39218474-B48124FE-2B96-44CB-B8D2-A0AE83CAAB50Q39444891-A1E04A15-5C6F-4247-9F61-9E99B0166DBDQ43405267-9E0A0FD5-C463-4C95-9034-E180415F9EEEQ43479634-08963B2D-DBD1-4BE3-9AF6-6D6E8BAE42C2Q44883261-BA1B4625-3EA6-4D89-A902-778939A4DA3EQ49665810-985EAFF5-E3CD-4A5B-8929-349B88253CEDQ50087591-75F25658-875B-4891-8E86-B8584B0F8FF8Q50668490-99EDB02B-E36A-4435-B21D-A806D4F872D0Q55217469-550C09AB-B7C3-45BA-A385-6B7E8F062A77
P2860
Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Treatment of newly diagnosed d ...... amine zinc and lente insulins.
@en
Treatment of newly diagnosed d ...... amine zinc and lente insulins.
@nl
type
label
Treatment of newly diagnosed d ...... amine zinc and lente insulins.
@en
Treatment of newly diagnosed d ...... amine zinc and lente insulins.
@nl
prefLabel
Treatment of newly diagnosed d ...... amine zinc and lente insulins.
@en
Treatment of newly diagnosed d ...... amine zinc and lente insulins.
@nl
P2093
P2860
P1476
Treatment of newly diagnosed d ...... amine zinc and lente insulins.
@en
P2093
J M Morton
R D Marshall
P2860
P304
P356
10.1016/J.JFMS.2009.05.016
P577
2009-06-18T00:00:00Z